Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    11986408 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Intervention: Drug: Anti-Tumor Necrosis Factor
2 Completed Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study
Conditions: Spondylitis, Ankylosing;   Recurrence
Intervention: Drug: Etanercept

Study has passed its completion date and status has not been verified in more than two years.